Home Cart Sign in  
Chemical Structure| 139481-28-0 Chemical Structure| 139481-28-0

Structure of 139481-28-0

Chemical Structure| 139481-28-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 139481-28-0 ]

CAS No. :139481-28-0
Formula : C22H17N3O4
M.W : 387.39
SMILES Code : O=C(OC)C1=CC=CC([N+]([O-])=O)=C1NCC2=CC=C(C3=CC=CC=C3C#N)C=C2
MDL No. :MFCD09029084
InChI Key :ZIRAEAZVSCADHC-UHFFFAOYSA-N
Pubchem ID :15654651

Safety of [ 139481-28-0 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 139481-28-0 ] Show Less

Physicochemical Properties

Num. heavy atoms 29
Num. arom. heavy atoms 18
Fraction Csp3 0.09
Num. rotatable bonds 7
Num. H-bond acceptors 5.0
Num. H-bond donors 1.0
Molar Refractivity 110.49
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

107.94 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.87
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

4.98
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

4.19
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.58
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.49
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

3.42

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-5.38
Solubility 0.00163 mg/ml ; 0.0000042 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-6.99
Solubility 0.00004 mg/ml ; 0.000000103 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Poorly soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-7.36
Solubility 0.0000168 mg/ml ; 0.0000000434 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Poorly soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

Yes
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

Yes
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

Yes
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.13 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

2.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<2.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

3.09

Application In Synthesis of [ 139481-28-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 139481-28-0 ]

[ 139481-28-0 ] Synthesis Path-Downstream   1~3

  • 1
  • [ 57113-90-3 ]
  • [ 139481-28-0 ]
  • 3
  • [ 57113-90-3 ]
  • [ 114772-54-2 ]
  • [ 139481-28-0 ]
YieldReaction ConditionsOperation in experiment
2-Tert-butoxy carbonylamino-3-nitro benzoic acid methyl ester (400 gm) was dissolved in toluene (2000 ml) and then added potassium carbonate (400 gm) at room temperature. 4-(2-cyanophenyl)benzyl bromide (400 gm) and Tetra-n-butylammonium bromide were added to the reaction mass. Gradually temperature raised to 80 to 85C. The reaction mass maintained for 12 hours at 80 to 85C. The reaction mass was cooled to room temperature and filtered on hiflo-bed. Collected the filtrate and concentrated to remove toluene. To the residue was added methanol (800 ml) and cooled to room temperature. The reaction mass was stirred for 4 hours at room temperature and filtered. Methanol (2900 ml) was added to the wet compound obtained and then added concentrated hydrochloric acid (725 ml) at room temperature. The reaction mass was heated to reflux and maintained for 3 hours at reflux. The reaction mass was further cooled to room temperature and filtered. Methanol (2900 ml) was added to the wet compound obtained and stirred for 45 minutes at room temperature. The separated solid was filtered and dried at 45 to 50C for 6 hours to obtain 450 gm of 2-(2'-cyanobiphenyl- 4-yl-methylamino)-3-nitro benzoic acid methyl ester.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 139481-28-0 ]

Aryls

Chemical Structure| 136285-67-1

A130646 [136285-67-1]

Ethyl-2-[[(2'-cyanobiphenyl-4-yl)methyl]amino]-3-nitrobenzoate

Similarity: 0.98

Chemical Structure| 136285-69-3

A231602 [136285-69-3]

Ethyl 3-amino-2-(((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)amino)benzoate

Similarity: 0.84

Chemical Structure| 350797-56-7

A350878 [350797-56-7]

3-(7-Cyano-5-(2-nitropropyl)indolin-1-yl)propyl benzoate

Similarity: 0.78

Chemical Structure| 57113-91-4

A104712 [57113-91-4]

Methyl 2-amino-3-nitrobenzoate

Similarity: 0.77

Chemical Structure| 99066-80-5

A191102 [99066-80-5]

Methyl 3-cyano-5-nitrobenzoate

Similarity: 0.76

Esters

Chemical Structure| 136285-67-1

A130646 [136285-67-1]

Ethyl-2-[[(2'-cyanobiphenyl-4-yl)methyl]amino]-3-nitrobenzoate

Similarity: 0.98

Chemical Structure| 136285-69-3

A231602 [136285-69-3]

Ethyl 3-amino-2-(((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)amino)benzoate

Similarity: 0.84

Chemical Structure| 350797-56-7

A350878 [350797-56-7]

3-(7-Cyano-5-(2-nitropropyl)indolin-1-yl)propyl benzoate

Similarity: 0.78

Chemical Structure| 57113-91-4

A104712 [57113-91-4]

Methyl 2-amino-3-nitrobenzoate

Similarity: 0.77

Chemical Structure| 443144-24-9

A103437 [443144-24-9]

Methyl 3-cyano-1H-indole-7-carboxylate

Similarity: 0.77

Amines

Chemical Structure| 136285-67-1

A130646 [136285-67-1]

Ethyl-2-[[(2'-cyanobiphenyl-4-yl)methyl]amino]-3-nitrobenzoate

Similarity: 0.98

Chemical Structure| 136285-69-3

A231602 [136285-69-3]

Ethyl 3-amino-2-(((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)amino)benzoate

Similarity: 0.84

Chemical Structure| 57113-91-4

A104712 [57113-91-4]

Methyl 2-amino-3-nitrobenzoate

Similarity: 0.77

Chemical Structure| 36242-50-9

A153631 [36242-50-9]

Methyl 4-(methylamino)-3-nitrobenzoate

Similarity: 0.76

Chemical Structure| 7356-52-7

A118079 [7356-52-7]

3-Acetamido-4-methyl-2-nitrobenzoic acid

Similarity: 0.75

Nitroes

Chemical Structure| 136285-67-1

A130646 [136285-67-1]

Ethyl-2-[[(2'-cyanobiphenyl-4-yl)methyl]amino]-3-nitrobenzoate

Similarity: 0.98

Chemical Structure| 350797-56-7

A350878 [350797-56-7]

3-(7-Cyano-5-(2-nitropropyl)indolin-1-yl)propyl benzoate

Similarity: 0.78

Chemical Structure| 57113-91-4

A104712 [57113-91-4]

Methyl 2-amino-3-nitrobenzoate

Similarity: 0.77

Chemical Structure| 36242-50-9

A153631 [36242-50-9]

Methyl 4-(methylamino)-3-nitrobenzoate

Similarity: 0.76

Chemical Structure| 99066-80-5

A191102 [99066-80-5]

Methyl 3-cyano-5-nitrobenzoate

Similarity: 0.76

Nitriles

Chemical Structure| 136285-67-1

A130646 [136285-67-1]

Ethyl-2-[[(2'-cyanobiphenyl-4-yl)methyl]amino]-3-nitrobenzoate

Similarity: 0.98

Chemical Structure| 136285-69-3

A231602 [136285-69-3]

Ethyl 3-amino-2-(((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)amino)benzoate

Similarity: 0.84

Chemical Structure| 350797-56-7

A350878 [350797-56-7]

3-(7-Cyano-5-(2-nitropropyl)indolin-1-yl)propyl benzoate

Similarity: 0.78

Chemical Structure| 443144-24-9

A103437 [443144-24-9]

Methyl 3-cyano-1H-indole-7-carboxylate

Similarity: 0.77

Chemical Structure| 99066-80-5

A191102 [99066-80-5]

Methyl 3-cyano-5-nitrobenzoate

Similarity: 0.76